A recent study in our lab demonstrated that WWOX suppresses Myc levels and activity in triple-negative breast cancer cell lines, by which WWOX binds the Myc transcription factor on the chromatin and modulates its activity on target genes. The gene discussed is WWOX; the disease is triple-negative breast carcinoma.